Tyche Industries Ltd

Tyche Industries Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tyche Industries Ltd

₹ 146 0.48%
04 Jul - close price
tycheindustries.net BSE: 532384
About

Incorporated in 1998, Tyche Industries Ltd
does manufacturing of active pharmaceutical ingredients[1]

Key Points

Business Overview:[1]
Company is a manufacturer and exporter of APIs, Intermediates and Nutraceuticals. It is one of the largest Indian manufacturers of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe

Website BSE
  • Market Cap ₹ 149 Cr.
  • Current Price ₹ 146
  • High / Low ₹ 224 / 129
  • Stock P/E 12.0
  • Book Value ₹ 133
  • Dividend Yield 1.72 %
  • ROCE 12.7 %
  • ROE 9.42 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 1.09 times its book value

Cons

  • The company has delivered a poor sales growth of -2.34% over past five years.
  • Company has a low return on equity of 10.7% over last 3 years.
  • Earnings include an other income of Rs.7.42 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
16.27 15.35 14.71 20.04 25.29 17.05 16.04 22.22 14.20 15.52 19.84 17.75 12.37
13.96 11.98 12.52 14.61 20.13 14.25 12.91 17.39 12.32 12.90 15.82 12.92 12.55
Operating Profit 2.31 3.37 2.19 5.43 5.16 2.80 3.13 4.83 1.88 2.62 4.02 4.83 -0.18
OPM % 14.20% 21.95% 14.89% 27.10% 20.40% 16.42% 19.51% 21.74% 13.24% 16.88% 20.26% 27.21% -1.46%
1.20 1.34 1.33 1.10 0.94 1.29 1.53 1.51 1.59 1.52 1.84 2.04 2.01
Interest -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Depreciation 0.42 0.48 0.39 0.43 0.48 0.46 0.47 0.48 0.54 0.49 0.49 0.50 0.50
Profit before tax 3.09 4.23 3.13 6.10 5.62 3.63 4.19 5.86 2.93 3.65 5.37 6.37 1.33
Tax % 25.89% 25.30% 25.56% 25.08% 27.05% 25.07% 25.30% 26.79% 28.67% 24.93% 25.51% 25.75% 28.57%
2.29 3.17 2.33 4.57 4.10 2.71 3.14 4.29 2.10 2.73 3.99 4.74 0.94
EPS in Rs 2.23 3.09 2.27 4.46 4.00 2.64 3.06 4.19 2.05 2.66 3.89 4.62 0.92
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
104 64 54 43 52 54 74 78 62 75 70 65
94 57 51 37 43 45 52 54 51 59 57 54
Operating Profit 11 7 3 6 9 9 21 25 11 16 13 11
OPM % 10% 11% 5% 14% 18% 17% 29% 32% 18% 21% 18% 17%
0 0 2 2 2 3 4 4 3 5 6 7
Interest 1 1 0 0 0 -0 -0 0 -0 -0 -0 -0
Depreciation 1 3 2 2 2 2 2 2 2 2 2 2
Profit before tax 8 3 3 6 9 10 23 27 13 19 17 17
Tax % 32% 33% 4% 48% 34% 27% 25% 25% 26% 26% 26% 26%
6 2 2 3 6 7 18 20 9 14 12 12
EPS in Rs 5.39 1.88 2.41 3.00 5.72 6.98 17.13 19.49 9.10 13.82 11.94 12.11
Dividend Payout % 9% 26% 21% 17% 9% 7% -0% 5% 16% -0% 21% 25%
Compounded Sales Growth
10 Years: 0%
5 Years: -2%
3 Years: 2%
TTM: -6%
Compounded Profit Growth
10 Years: 20%
5 Years: -7%
3 Years: 8%
TTM: 1%
Stock Price CAGR
10 Years: 14%
5 Years: 3%
3 Years: 7%
1 Year: -19%
Return on Equity
10 Years: 13%
5 Years: 13%
3 Years: 11%
Last Year: 9%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 10
Reserves 33 34 35 38 43 50 67 86 94 107 116 126
11 9 11 -0 0 0 -0 -0 -0 -0 -0 -0
19 12 11 13 14 14 18 21 16 20 10 11
Total Liabilities 74 64 67 61 67 74 95 117 120 137 137 147
33 29 28 27 20 19 18 18 17 17 18 16
CWIP 0 0 0 0 -0 -0 -0 1 -0 -0 -0 0
Investments -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
40 35 39 34 47 55 77 98 104 120 119 131
Total Assets 74 64 67 61 67 74 95 117 120 137 137 147

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
9 2 12 11 5 4 15 15 4 6 8 9
-6 -1 -1 1 6 1 2 0 3 -3 4 -1
0 -3 2 -11 -1 -0 -1 -1 -1 -2 -2 -3
Net Cash Flow 3 -2 12 1 11 4 17 15 7 2 10 5

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 46 91 107 81 68 69 64 80 96 107 100 95
Inventory Days 91 138 68 84 85 123 122 148 148 195 157 245
Days Payable 68 76 93 130 87 96 91 93 78 134 48 85
Cash Conversion Cycle 69 153 82 34 67 96 94 135 167 168 210 255
Working Capital Days 68 122 89 60 67 87 77 83 121 129 144 151
ROCE % 18% 7% 5% 12% 18% 17% 34% 32% 13% 17% 14% 13%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
61.97% 61.97% 61.97% 61.97% 61.97% 61.97% 61.97% 61.97% 61.97% 61.97% 61.97% 61.97%
38.03% 38.04% 38.03% 38.04% 38.04% 38.04% 38.04% 38.03% 38.03% 38.03% 38.03% 38.03%
No. of Shareholders 8,8448,6398,4658,2818,7558,4618,2217,8677,4777,2647,3087,425

Documents

Announcements

Annual reports

Credit ratings